Cashu | Summary

DJI

-0.45%

SPX

+0.33%

IXIC

+0.97%

FTSE

+0.37%

N225

-0.88%

AXJO

-1.82%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

HomeWatchlistNewsSignalsPicks

DJI

-0.45%

SPX

+0.33%

IXIC

+0.97%

FTSE

+0.37%

N225

-0.88%

AXJO

-1.82%

HomeWatchlistNewsSignalsPicks

Overview

Loading chart...

Join our newsletter to keep up to date with us!

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

Overview

Loading chart...

Join our newsletter to keep up to date with us!

About

What does ONC do?

It seems there was an error or missing information in your request. Please provide the content you would like summarized, and I'll be happy to help!

Sector

💻 Health Care

IPO

CEO

Employees

11,000

Headquarters

Cayman Islands

Website

http://www.beigene.com

Key Stats

Market Cap

35.88B

Dividend Yield

0.00%

P/E Ratio

-201.97

EPS

-0.48

Revenue

3.81B

Avg. Volume

381.30K

Recently from Cashu

Cashu

BeOne Medicines Reports Promising Results for Sonrotoclax in Relapsed Mantle Cell Lymphoma

2 days ago

Cashu

BeiGene Advances Sonrotoclax Research for Relapsed/Refractory Mantle Cell Lymphoma Treatment

4 days ago

Cashu

BeiGene: BeOne Medicines Sells Royalty Rights to Capitalize on Oncology Market Potential

6 days ago

Stocks

Health Care

onc

BeiGene

SHANGHAI STOCK EXCHANGE: ONC

+26.21 (0.00%)

332.265

USD

At close at Sep 03, 13:26 UTC